[Abstract Only] Randomized Trial: Dexamethasone for the Treatment of Acute Respiratory Distress Syndrome
12 Feb, 2020 | 07:24h | UTCDexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Related: Meta-Analysis: Assessment of Therapeutic Interventions and Lung Protective Ventilation in Patients with Moderate to Severe Acute Respiratory Distress Syndrome (free resources on the subject)
Related Commentary on Twitter
#Dexamethasone is associated with a substantial reduction in duration of mechanical #ventilation and all-cause 60-day #mortality in patients with #ARDS
New RCT from Jesús ViIlar and colleagues https://t.co/b4sW2K0RwG pic.twitter.com/MBbeSWBo55
— The Lancet Respiratory Medicine (@LancetRespirMed) February 10, 2020